Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder
characterized by the combined occurrence of parathyroid, pancreatic islet and anterior …

Jensen RT (Bethesda, MD, USA). Management of the Zollinger–Ellison syndrome in patients
with multiple endocrine neoplasia type 1 (Minisymposium: MEN & VHL). J Intern Med 1998; …

Objective: To evaluate the outcome of an aggressive surgical approach for
duodenopancreatic neuroendocrine tumors (PETs) associated with multiple endocrine …

Purpose This study was made to evaluate long-term results of an aggressive surgical
approach for pancreaticoduodenal neuroendocrine neoplasms (pNENs) in patients with …

Pancreaticoduodenal tumors develop in a majority of patients with multiple endocrine
neoplasia type 1 (MEN 1) and have a pronounced effect on life expectancy as the principal …

The clinical evolution of type I multiple endocrine neoplasia (MEN I) was studied in 45
patients among a consecutive series of 172 with Zollinger-Ellison syndrome (ZES). These …

AIM: To search for the optimal surgery for gastrinoma and duodenopancreatic
neuroendocrine tumors in patients with multiple endocrine neoplasia type 1. METHODS …

Background. The management of pancreaticoduodenal endocrine tumors (PETs) remains
controversial in multiple endocrine neoplasia type 1 (MEN 1). Methods. Twenty-one patients …

Purpose: Recently, an increased incidence of some nonendocrine tumors are reported in
patients with multiple endocrine neoplasia type 1 (MEN 1). There are rare reports of …

Early identification of pancreaticoduodenal endocrine tumors (PETs) in multiple endocrine
neoplasia type 1 (MEN-1) is mandatory, because these tumors represent the most common …